These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9283991)

  • 1. Efficacy of lansoprazole against peptic ulcers induced by non-steroidal anti-inflammatory drugs: endoscopic evaluation of ulcer healing.
    Matsukawa Y; Tomita Y; Nishinarita S; Horie T; Kato K; Arakawa Y; Ko K; Shimada H; Nakano M; Kitami Y; Kurosaka H
    J Int Med Res; 1997; 25(4):190-5. PubMed ID: 9283991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial.
    Lai KC; Lam SK; Chu KM; Hui WM; Kwok KF; Wong BC; Hu HC; Wong WM; Chan OO; Chan CK
    Aliment Pharmacol Ther; 2003 Oct; 18(8):829-36. PubMed ID: 14535877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lansoprazole on peptic ulcers.
    Ohashi T; Sakata J; Haraguchi Y; Eto T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
    Arkkila PE; Seppälä K; Kosunen TU; Sipponen P; Mäkinen J; Rautelin H; Färkkilä M
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):93-101. PubMed ID: 15647648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of lansoprazole treatment on the healing and relapse of peptic ulcer and serum levels of IgG anti-Helicobacter pylori antibody.
    Mine T; Yasuda H; Akimoto K; Katoaka A; Mashima H; Tajima A; Fukujin H; Tsuchida T; Takano T; Nagasawa J
    J Clin Gastroenterol; 1995; 20 Suppl 2():S75-8. PubMed ID: 7594347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
    Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
    Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
    Ogoshi K; Kato T; Sakagawa T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S97-9. PubMed ID: 7594354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors for Helicobacter pylori eradication in patients with peptic ulcer.
    Yamamoto I; Fukuda Y; Okui M; Tamura K; Shimoyama T
    J Clin Gastroenterol; 1995; 20 Suppl 1():S38-42. PubMed ID: 7673613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of lansoprazole on peptic ulcers in elderly patients.
    Murakami M; Saita H; Takahashi Y; Kusaka S; Asagoe K; Dekigai H; Matsumoto M; Seki M; Mizuno M; Maeda S
    J Clin Gastroenterol; 1995; 20 Suppl 2():S79-82. PubMed ID: 7594348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
    Graham DY; Agrawal NM; Campbell DR; Haber MM; Collis C; Lukasik NL; Huang B;
    Arch Intern Med; 2002 Jan; 162(2):169-75. PubMed ID: 11802750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II.
    Matsukawa Y; Nishinarita S; Kaneko M; Takei M; Murakami M; Horie T; Kawamura F; Arakawa Y; Kuwayama H; Kurosaka H
    Int J Clin Pharmacol Res; 1997; 17(4):127-32. PubMed ID: 9526173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.